1,125 results on '"Diamant, M"'
Search Results
2. Influence of prednisolone on parameters of de novo lipogenesis and indices for stearoyl-CoA- and Δ6- desaturase activity in healthy males: A Post-hoc analysis of a randomized, placebo-controlled, double-blind trial
3. Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials
4. Progression in attenuating myocardial reperfusion injury: An overview
5. The longitudinal association between glycaemic control and health-related quality of life following insulin therapy optimisation in type 2 diabetes patients. A prospective observational study in secondary care
6. The good, the bad, and the divergent in game-based learning:player experiences of a serious game for climate change engagement
7. Accepting Kidneys from Older Living Donors: Impact on Transplant Recipient Outcomes
8. Management of hyperglycaemia in type 2 diabetes
9. Glucagon-like peptide-1 receptor agonist exenatide has no acute effect on MRI-measured exocrine pancreatic function in patients with type 2 diabetes: a randomized trial
10. Brain reward-system activation in response to anticipation and consumption of palatable food is altered by glucagon-like peptide-1 receptor activation in humans
11. Uruguayan Experience With Cryopreserved Arterial Homografts
12. Effects of induced hyperinsulinaemia with and without hyperglycaemia on measures of cardiac vagal control
13. Postprandial microvascular function deteriorates in parallel with gradual worsening of insulin sensitivity and glucose tolerance in men with the metabolic syndrome or type 2 diabetes
14. Steroid diabetes (revision number 19)
15. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
16. Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study
17. Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetes
18. Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial
19. Beta cell function following 1 year vildagliptin or placebo treatment and after 12 week washout in drug-naive patients with type 2 diabetes and mild hyperglycaemia: a randomised controlled trial
20. The heritability of beta cell function parameters in a mixed meal test design
21. Postprandial glucose and not triglyceride concentrations are associated with carotid intima media thickness in women with normal glucose metabolism: The Hoorn prandial study
22. Is insulin the most effective injectable antihyperglycaemic therapy?
23. Diabetes-specific emotional distress in people with Type 2 diabetes: a comparison between primary and secondary care
24. Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and Type 2 diabetes susceptibility
25. Genetic influences on the insulin response of the beta cell to different secretagogues
26. Het metabool syndroom bij kinderen met overgewicht en obesitas in Amsterdam-West: Welke definitie identificeert kinderen met een hoog risico?
27. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification
28. Effect of a hypercaloric and hypocaloric diet on insulin-induced microvascular recruitment, whole-body glucose uptake and adipose tissue lipolysis
29. Steroid diabetes (revision number 18)
30. Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats
31. A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism—The Hoorn Study
32. Review article: the role of gastrointestinal hormones in the treatment of delayed gastric emptying in critically ill patients
33. Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes
34. No Difference in Glycosphingolipid Metabolism and Mitochondrial Function in Glucocorticoid-Induced Insulin Resistance in Healthy Men
35. Two consecutive high‐fat meals affect endothelial‐dependent vasodilation, oxidative stress and cellular microparticles in healthy men
36. Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions
37. Impact of postprandial glycaemia on health and prevention of disease
38. Glucocorticoid receptor gene polymorphisms are associated with reduced first-phase glucose-stimulated insulin secretion and disposition index in women, but not in men
39. GLP-1 based therapies: differential effects on fasting and postprandial glucose
40. Does interference with the renin–angiotensin system protect against diabetes? Evidence and mechanisms
41. Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment
42. GENDER DIFFERENCES IN SKELETAL MUSCLE FATTY ACID HANDLING IN RELATION TO INSULIN RESISTANCE: 423 accepted poster
43. DIFFERENT SKELETAL MUSCLE FATTY ACID HANDLING IN SUBJECTS WITH IMPAIRED FASTING GLUCOSE AND IMPAIRED GLUCOSE TOLERANCE: 147 accepted oral
44. Impaired insulin sensitivity is accompanied by disturbances in skeletal muscle fatty acid handling in subjects with impaired glucose metabolism
45. P210Early diagnostic markers for NSTEMI preceeding troponine
46. Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence
47. Lisinopril versus enalapril: evaluation of trough:peak ratio by ambulatory blood pressure monitoring
48. Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids
49. Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care
50. Do nutrient–gut–microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.